Adherence to preventive statin therapy according to socioeconomic position
- 16 April 2013
- journal article
- pharmacoepidemiology and-prescription
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 69 (8) , 1553-1563
Abstract
Aim To explore whether long-term adherence to preventive statin therapy depends on socioeconomic position (SEP). Methods A cohort of individuals without established cardiovascular disease (CVD) or diabetes initiating preventive statin therapy during 2002–2005 was followed in the individual-level Danish registries for 4 years or until censoring events (death, emigration, CVD or diabetes). Only individuals aged 40–84 years for whom information was available on the SEP indicators, education and income were included (N = 76,038). Two different aspects of poor adherence were applied as outcome measures: (1) Proportion of days covered (PDC) with medication below 80 %, assuming a daily dose of one tablet (continuity); (2) Discontinuation defined as a gap between two consecutive prescriptions exceeding 365 days (persistence). Stratum-specific logistic regression analyses were applied to estimate the odds ratio (OR) for PDC <80 % across SEP, adjusting for age and hypertension. Hazard ratio (HR) for discontinuation was estimated by Cox regression analyses. Results Adjusting mutually for income and education, the OR for PDC <80 % decreased with increasing income. Comparing the highest income quintile with the lowest, the OR were 0.64 (95 % Confidence Interval 0.64–0.65) and 0.73 (0.73–0.74) in men aged 40–64 and 65–84 years, respectively; in women, the figures were 0.79 (0.79–0.79) and 0.95 (0.94–0.95), respectively. While observed increases in adherence with longer education in unadjusted analyses were attenuated after adjustment for income among men, the potential inverse relationship between length of education and adherence was enhanced among women. Applying discontinuation as outcome, analogous differences were demonstrated. Conclusion Adherence to preventive statin therapy in Denmark decreases with decreasing income—especially in men aged 40–64 years.Keywords
This publication has 68 references indexed in Scilit:
- Income-Related Inequity in Initiation of Evidence-Based Therapies Among Patients with Acute Myocardial InfarctionJournal of General Internal Medicine, 2011
- Healthy User and Related Biases in Observational Studies of Preventive Interventions: A Primer for PhysiciansJournal of General Internal Medicine, 2011
- Statin adherence and the risk of major coronary events in patients with diabetes: a nested case–control studyBritish Journal of Clinical Pharmacology, 2010
- Driving forces behind increasing cardiovascular drug utilization: a dynamic pharmacoepidemiological modelBritish Journal of Clinical Pharmacology, 2008
- Closing the gap in a generation: health equity through action on the social determinants of healthThe Lancet, 2008
- Use of statins and beta-blockers after acute myocardial infarction according to income and educationJournal of Epidemiology and Community Health, 2007
- Impact of adherence to statins on coronary artery disease in primary preventionBritish Journal of Clinical Pharmacology, 2007
- Effectiveness and efficiency of different guidelines on statin treatment for preventing deaths from coronary heart disease: modelling studyBMJ, 2006
- American, British and European recommendations for statins in the primary prevention of cardiovascular disease applied to British men studied prospectivelyHeart, 2006
- Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic reviewHeart, 2006